Active Ingredient: FOSDENOPTERIN HYDROBROMIDE
Proprietary Name: NULIBRY
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 9.5MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214018
Product Number: 001
Approval Date: Feb 26, 2021
Applicant Holder Full Name: SENTYNL THERAPEUTICS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
